ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc (MXCT)., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling ...
MaxCyte, Inc. announced a strategic platform license agreement with TG Therapeutics, a biopharmaceutical company specializing in treatments for B-cell diseases. Under this agreement, TG Therapeutics ...
BOSTON and BORDEAUX, France, April 23, 2024 /PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback